Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study tested whether a new version of a long-acting schizophrenia injection works the same as the current standard. 256 Chinese adults with stable schizophrenia received multiple doses of either the test or reference injection. The goal was to confirm the two medications rea…

This study tested a new injection called SYH2053 in 156 adults with high cholesterol or mixed high blood fats. Participants either received the new drug, a placebo (dummy shot), or an active comparator. The main goal was to see how much the drug lowered "bad" LDL cholesterol comp…